Investigating Near-Threshold Perception During Anesthetic Sedation
Launched by UNIVERSITY OF MICHIGAN · May 3, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand how our minds work during different levels of anesthesia, specifically when using a medication called propofol, which is commonly used to help people relax before surgery. The researchers also want to see if a special technique called ultrasonic brain stimulation can help people wake up faster after being sedated.
To participate in this study, you need to be a healthy adult aged between 18 and 65, right-handed, and with a body mass index (BMI) of less than 30. You should speak English and not have any conditions that would make it unsafe for you to undergo an MRI scan, which is a type of imaging test used in the study. If you join, you can expect to receive propofol while your brain activity is monitored, helping researchers learn more about how anesthesia affects consciousness. It's important to know that participants must avoid alcohol for 24 hours before the study and that certain medical histories, like severe allergies, or specific tattoos, may prevent someone from joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy study subjects with American Society of Anesthesiologists (ASA)-1 status.
- • Right-handed
- • Body mass index (BMI) less than 30.
- • All subjects will be English speakers.
- Exclusion Criteria:
- • Medical contraindication to magnetic resonance imaging (MRI) scanning; are unable to undergo MRI scanning because of possible pregnancy or currently breastfeeding, BMI\>30, metallic substances in the body, claustrophobia, anxiety, or cardiopulmonary disease; or have an intracranial structural abnormality on T1-weighted MRI scans.
- • History of allergy to propofol, eggs or egg products, soybean or soybean products, neurological, cardiovascular, or pulmonary illness; significant head injury with loss of consciousness; learning disability or other developmental disorder; sleep apnea or any severe snoring history; gastroesophageal reflux disease (GERD) or heartburn; pancreatitis or a history of pancreatitis, or sensory/motor loss sufficient to interfere with performance of the study.
- • Tattoos in the head or neck region will be excluded from study; other tattoos are subject to determination by investigators based on their assessment regarding participant safety. To eliminate aspiration risk subjects will also be excluded if they have had recent food or liquid intake (within 8 hours).
- • History of drug use, have a positive drug screen, are unwilling to abstain from alcohol for 24 hours prior to dosing, or have a current history of nicotine use.
- • Pregnancy
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Zirui Huang
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported